Research Topics
Species | Sylvie EuvrardSummaryAffiliation: Clinique du Parc Monceau Country: France Publications
| Collaborators
|
Detail Information
Publications
Sirolimus and secondary skin-cancer prevention in kidney transplantationSylvie Euvrard
Department of Dermatology, Hospices Civils de Lyon, Edouard Herriot Hospital Group, Lyon, France
N Engl J Med 367:329-39. 2012..Transplant recipients in whom cutaneous squamous-cell carcinomas develop are at high risk for multiple subsequent skin cancers. Whether sirolimus is useful in the prevention of secondary skin cancer has not been assessed...
Subsequent skin cancers in kidney and heart transplant recipients after the first squamous cell carcinomaSylvie Euvrard
Department of Dermatology, Edouard Herriot Hospital, Lyon, France
Transplantation 81:1093-100. 2006..The aim of this study was to compare the individual rate of subsequent skin cancers in kidney (KTR) and heart transplant recipients (HTR) after the first squamous cell carcinoma (SCC) and to assess risk factors for tumor multiplicity...
Immunosuppressants and skin cancer in transplant patients: focus on rapamycinSylvie Euvrard
Department of Dermatology, Edouard Herriott Hospital, Lyon, France
Dermatol Surg 30:628-33. 2004..Discerning the role of each drug is complicated owing to the fact that most patients generally have combinations of several medications...
Skin cancers following pediatric organ transplantationSylvie Euvrard
Dermatology Department, Hopital Edouard Herriott, Lyon, France
Dermatol Surg 30:616-21. 2004..Although several studies have been devoted to adult transplant patients, few data are available on the long-term skin malignancies following pediatric organ transplantation...
Skin cancers after liver transplantation: what to do?Sylvie Euvrard
Department of Dermatology, Edouard Herriot Hospital Pav R, 5 Place d Arsonval, 69437 Lyon Cedex 03, France
J Hepatol 44:27-32. 2006
[Skin cancers after organ transplants]Sylvie Euvrard
Service de Dermatologie, Hopital Edouard Herriot, F 69437 Lyon Cedex 03, France
Presse Med 37:1475-9. 2008..Primary prevention requires that patients be educated about strict sun protection from the transplant onwards and have a routine annual dermatologic examination enabling early treatment of lesions...
Skin cancers after organ transplantationSylvie Euvrard
Department of Dermatology, Edouard Herriot Hospital, Lyons, France
N Engl J Med 348:1681-91. 2003
[Cutaneous tumors in organ transplant recipients]Sylvie Euvrard
Service de Dermatologie, Hopital Edouard Herriot, place d Arsonval 69437 Lyon
Presse Med 31:1895-903. 2002..The factors enhancing Kaposi's sarcoma associated with the HHV8 virus remain to be defined. The possibility of transmission of the infection through the graft must lead to the systematic search for this virus in the donors...
Conversion from calcineurin inhibitors to sirolimus reduces vascularization and thickness of post-transplant cutaneous squamous cell carcinomasAnne Laure Rival-Tringali
Hospices Civils de Lyon, Hospital Edouard Herriot, Clinique Dermatologique Pav R, 69437 Lyon Cedex 03, France
Anticancer Res 29:1927-32. 2009..An investigation was undertaken into the effects of SRL on squamous cell carcinoma (SCC) developing in organ transplant recipients (OTR) receiving immunosuppressive treatments, with special emphasis on vascularization...
Squamous cell carcinomas are associated with verrucokeratotic cutaneous lesions but not with common warts in organ-transplant patients. A case-control studyPascal Joly
Department of Dermatology, Rouen University Hospital, University of Rouen, Rouen, France
Transplantation 89:1224-30. 2010..Warts are thought to be associated with the development of squamous cell carcinoma (SCC) in organ transplant patients. We investigated the association between the different types of warts and SCC in organ transplant patients...
Basal cell carcinomas developing in solid organ transplant recipients: clinicopathologic study of 176 casesJean Kanitakis
Department of Dermatology, Edouard Herriot Hospital, Lyon, France
Arch Dermatol 139:1133-7. 2003..To assess the clinicopathologic features of basal cell carcinomas developing in organ transplant recipients...
Trichilemmal carcinoma of the skin mimicking a keloid in a heart transplant recipientJean Kanitakis
Department of Dermatology, Ed Herriot Hospital, Lyon, France
J Heart Lung Transplant 26:649-51. 2007..We describe the first case of trichilemmal carcinoma presenting with a misleading clinical aspect in a heart transplant recipient. We then briefly outline the salient clinicopathologic features of this malignancy...
No recurrence of posttransplantation Kaposi's sarcoma three years after renal retransplantationSylvie Euvrard
Department of Dermatology, Ed Herriot Hospital, Lyon, France
Transplantation 73:297-9. 2002..This unique observation suggests that retransplantation of patients with previous posttransplantation KS is possible...
Bowen's Disease masquerading clinically as a follicular cyst in a renal transplant recipientJean Kanitakis
Department of Dermatology, Ed Herriot Hospital, Lyon, France
Am J Dermatopathol 29:412-3. 2007..We speculate that this lesion developed from pre-existing Bowen's disease extending to the hair follicles...
Cutaneous cryptococcosis in solid organ transplant recipients: epidemiological, clinical, diagnostic and therapeutic featuresDoriane Biancheri
Department of Dermatology, Edouard Herriot Hospital Group, Lyon, France
Eur J Dermatol 22:651-7. 2012..Evidence of dissemination is difficult because of the poor sensitivity of diagnostic tests. Fluconazole was the treatment of choice in association with immunosuppressive treatment tapering...
Basosquamous cell carcinoma in organ transplant patients: a clinicopathologic studyFanny Mougel
Department of Dermatology, Edouard Herriot Hospital Group, Lyon, France
J Am Acad Dermatol 66:e151-7. 2012..Basosquamous cell carcinoma (BSCC) is a poorly known tumor showing pathological features of both basal and squamous cell carcinomas. BSCC has never been specifically studied in organ transplant recipients (OTRs)...
Rapidly growing orf in a renal transplant recipient: favourable outcome with reduction of immunosuppression and imiquimodDaniela Zaharia
Department of Dermatology, Edouard Herriot Hospital Group, Hospices Civils de Lyon, Lyon, France
Transpl Int 23:e62-4. 2010..This case suggests that a rapidly growing orf in transplant patients behaves as an opportunistic infection and therefore minimization should be considered along with a topical treatment...
TP53 polymorphism of exon 4 at codon 72 in cutaneous squamous cell carcinoma and benign epithelial lesions of renal transplant recipients and immunocompetent individuals: lack of correlation with human papillomavirus statusSandrine Cairey-Remonnay
Department of Cell Biology, IETG EA 2085, Besancon, Department of Dermatology, Department of Pathology, and Department of Statistics, Besancon, Department of Dermatology, Lyon, France
J Invest Dermatol 118:1026-31. 2002..No association between TP53 arginine/arginine genotype and human papillomavirus status could be determined, however...
BRAF mutations in melanocytic tumors (nevi and melanomas) from organ transplant recipientsJean Kanitakis
Department of Dermatology Laboratory of Dermatopathology, Ed Herriot Hospital, 69437 Lyon Cedex 03, France
Eur J Dermatol 20:167-71. 2010....
Malignancy incidence after renal transplantation in children: a 20-year single-centre experienceFoteini Koukourgianni
Centre de Référence des Maladies Rénales Rares, Hôpital Femme Mère Enfant et Université de Lyon, Lyon, France
Nephrol Dial Transplant 25:611-6. 2010..The pattern of malignancies that occur in the paediatric graft population is different from that in the general paediatric population and in the population of adult organ transplant recipients...
5% topical imiquimod tolerance in transplant recipientsAmel Mebazaa
Department of Dermatology, Saint Louis Hospital, Paris, France
Dermatology 215:130-3. 2007..Topical imiquimod is a new immunomodulator agent approved for genital warts, actinic keratosis (AK) or carcinoma, occurring in immunocompetent patients...
Keratotic skin lesions and other risk factors are associated with skin cancer in organ-transplant recipients: a case-control study in The Netherlands, United Kingdom, Germany, France, and ItalyJan N Bouwes Bavinck
Department of Dermatology, Leiden University Medical Center, Leiden, The Netherlands
J Invest Dermatol 127:1647-56. 2007....
Skin carcinoma arising from donor cells in a kidney transplant recipientSelim Aractingi
Unite de Dermatologie, Hopital Tenon, Paris, France
Cancer Res 65:1755-60. 2005..In conclusion, stem cells originating from a grafted kidney may migrate to the skin, differentiate, or fuse as keratinocytes that could, rarely, undergo cancer transformation...
Guidelines for the management of squamous cell carcinoma in organ transplant recipientsThomas Stasko
Vanderbilt University School of Medicine, Nashville, Tennessee, USA
Dermatol Surg 30:642-50. 2004..There are few published studies or reviews, which provide guidance to the clinician in the treatment of these patients...
Prognostic value of quantitative Kaposi sarcoma--associated herpesvirus load in posttransplantation Kaposi sarcomaClaire Pellet
Laboratory of Pharmacology, , Paris, France
J Infect Dis 186:110-3. 2002..01). Thus, quantification of KSHV load in peripheral blood mononuclear cells could represent a useful tool for monitoring transplant recipients with KS...
Skin cancers in organ transplant recipientsJean Kanitakis
J Am Acad Dermatol 54:1115. 2006
Complications of systemic retinoid therapy in organ transplant recipients with squamous cell carcinomaJuan-Carlos Martinez
Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
Dermatol Surg 30:662-6. 2004..Intolerance of adverse effects in this context suggests the need for novel approaches with these challenging patients...
Defining the clinical course of metastatic skin cancer in organ transplant recipients: a multicenter collaborative studyJuan-Carlos Martinez
Mayo Medical School, Rochester, MN, USA
Arch Dermatol 139:301-6. 2003..Preventive, early, and aggressive therapeutic interventions are required to minimize this serious complication of transplant-associated immunosuppression...
Selective expression of HLA-G in malignant and premalignant skin specimens in kidney transplant recipientsSelim Aractingi
Commissariat a l Energie Atomique, Hopital Saint Louis, Paris, France
Int J Cancer 106:232-5. 2003..Cytokines triggered in the course of organ transplantation include IL-10. This molecule may induce expression of HLA-G, which in turn may be implicated in tumor development in transplanted recipients...
Merkel cell carcinoma in organ-transplant recipients: report of two cases with unusual histological features and literature reviewJean Kanitakis
Department of Dermatology EA 37 32, University Cl Bernard, France
J Cutan Pathol 33:686-94. 2006..Merkel cell carcinoma is an uncommon neuroendocrine skin tumor, of which 67 cases have been reported up till now, usually briefly, in organ transplant patients...
Specialty clinics for the dermatologic care of solid-organ transplant recipientsLeslie J Christenson
Department of Dermatology, Mayo Clinic, Rochester, Minnesota 55905, USA
Dermatol Surg 30:598-603. 2004..Regardless of the clinic design used, an organized and firmly established clinic model to allow proactive and ongoing care for these patients is important for education, prevention, and early intervention...
[Graft versus host disease following liver transplantation. Favorable outcome after treatment with tacrolimus]Jerome Dumortier
Gastroenterol Clin Biol 27:561-2. 2003
Nontumoral dermatologic problems after liver transplantationEdmond Schmied
Center for Skin Diseases, La Chaux-de-Fonds, Switzerland
Liver Transpl 10:331-9. 2004..Our intent is to provide an overview of the current knowledge regarding nontumoral dermatologic problems associated with liver transplantation by summarizing the available information from all documented case reports...
Merkel cell carcinoma in immunocompetent and organ-transplant recipients do not harbor HPVJean Kanitakis
Eur J Dermatol 16:445-6. 2006
